Abstract Body

Background

Diabetes mellitus (DM) is a growing complication among people living with HIV (PLHIV), driven by traditional risk factors including age or obesity, as well as HIV-related factors such as exposure to certain antiretroviral therapy (ART). Dolutegravir (DTG), now the recommended first-line regimen in most settings, has been associated with metabolic disorders including weight gain, underscoring the need to assess DM incidence and its predictors in contemporary cohorts of PLHIV initiating ART in West Africa.

Methods

We conducted a retrospective cohort analysis using the IeDEA West Africa database from four HIV clinics in Abidjan, Cote d’Ivoire (n=3) and Bobo-Dioulasso, Burkina Faso (n=1) that collected routine fasting glycaemia from 2009 to 2023. Eligible adults were ART initiators with a baseline fasting glycaemia (±3 months) and ≥1 measure of fasting glycaemia during follow-up. Those with prevalent DM were excluded. Incident DM was defined as a first fasting glycaemia ≥7.0 mmol/L (≥126 mg/dL). We estimated the 2-year cumulative incidence and used cause-specific Cox models with time-varying Body Mass Index (BMI) and random effects on HIV clinics to identify predictors of DM.

Results

Among 9,171 participants (68% female; median age 38 years), 396 developed DM over 16,077 person-years, corresponding to an incidence rate of 2.46 per 100 person-years and a 2-year cumulative incidence of 4.8%. Prediabetes at ART initiation and Obesity were the strongest predictors of incident DM with aHR of 2.60, 95%CI 1.95–3.47, p<0.001) and 2.53 (95%CI 1.88–3.39, p<0.001), respectively. Men had twice the risk of DM compared to women (aHR 2.08, 95%CI 1.69–2.57, p<0.001). Risk also increased with age, with participants >55 years experiencing a 66% higher risk compared to those <35 years (aHR 1.66, 95%CI 1.13–2.43). Regarding ART regimen at initiation, DTG use nearly doubled the risk of DM compared to PLHIV initiated on efavirenz (aHR 1.94, 95%CI 1.38–2.74, p<0.001).

Conclusions

In this large West African cohort, male sex, older age, obesity, and prediabetes were major predictors of incident DM. Importantly, exposure to DTG at ART initiation was independently associated with a nearly doubled risk of DM compared to efavirenz. These findings highlight the need for enhanced and expanded DM screening of PLHIV in West Africa and a careful consideration of metabolic effects when initiating or switching to DTG.

Table or Figure